Table 15.1.
Approved influenza vaccines containing squalene as part of the vaccine adjuvant.
Adjuvants | Component | Vaccines | Trade name | Use (age group) | Manufacturer |
---|---|---|---|---|---|
MF59 | Squalene; polysorbate 80; sorbitan trioleate | Seasonal influenza vaccine | FLUAD FLUAD quadrivalent | 65 years and older | Novartis |
A/H1N1 pandemic influenza vaccine | Forcetria Celtura | 6 months and older | Novartis | ||
AS03 | Squalene; α-tocopherol; polysorbate 80 | A/H1N1 pandemic influenza vaccine | Pandemrix Prepandrix | 6 months and older 18 years and older | GlaxoSmithKline (GSK) |
AF03 | Squalene; polyoxyethylene cetostearyl ether; mannitol; sorbitan oleate | A/H1N1 pandemic influenza vaccine | Humenza | 6 months and older | Sanofi |
Reproduced under CC BY from Reference 20.